Literature DB >> 821385

Resistance of Brucella abortus infected mice to intravenous or intraperitoneal Brucella reinfection.

P Pardon, J Marly.   

Abstract

The development of acquired resistance to Brucella abortus was studied in mice infected intravenously with small numbers of live CO2-dependent B. abortus 544 used as vaccinal strain. CO2-independent B. abortus was used as challenge strain. The influence of several parameters in the development of acquired resistance was examined: vaccination--challenge interval, challenge route, dose of challenge, challenge-sacrifice interval. The behavior of the challenge strain in normal mice depended on the size of the inoculum. After an intravenous inoculum of about 1 X 10(6) bacteria, the level of infection in the liver or the spleen followed three phases: a phase of increase of the viable counts, a phase of decrease, and a phase of plateau. The decreasing phase was more pronounced in liver than in spleen. After an intraperitoneal injection of the same dose of bacteria, an infection developed following approximately the same pattern, except during the first day of infection. One month after vaccination by an inoculum of about 1 X 10(4) viable B. abortus, an accelerated appearance of the decreasing phase prevented almost completely the multiplication of an intravenous challenge of about 1 X 10(6) B. abortus in the spleens. In the livers the same phenomenon took place after a small increase of the bacterial population. After an intraperitoneal challenge, the numbers of Brucella isolated from the spleens and livers of vaccinated mice first fell sharply to practically nothing around the sixth day, and then rose to reach a phase of slow increase or of plateau until the twenty-fourth day. In our experimental conditions, the vaccine population remained undisturbed by the reinfecting inoculum.

Entities:  

Mesh:

Year:  1976        PMID: 821385

Source DB:  PubMed          Journal:  Ann Immunol (Paris)        ISSN: 0300-4910


  8 in total

1.  Immune responses and resistance to brucellosis in mice vaccinated orally with Brucella abortus RB51.

Authors:  M G Stevens; S C Olsen; M V Palmer; G W Pugh
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

2.  Plaque-forming cells in mice after experimental infection with Brucella abortus.

Authors:  S Schneerson-Porat; D Feinhaken; M Pinto
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

3.  Macrophage activation during experimental murine brucellosis: a basis for chronic infection.

Authors:  C Cheers; F Pagram
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

4.  The Ton system, an ABC transporter, and a universally conserved GTPase are involved in iron utilization by Brucella melitensis 16M.

Authors:  Isabelle Danese; Valerie Haine; Rose-May Delrue; Anne Tibor; Pascal Lestrate; Olivier Stevaux; Pascal Mertens; Jean-Yves Paquet; Jacques Godfroid; Xavier De Bolle; Jean-Jacques Letesson
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

5.  Immune serum-mediated effects on brucellosis evolution in mice.

Authors:  M Plommet; A M Plommet
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

6.  Bioluminescence Imaging of Colonization and Clearance Dynamics of Brucella Suis Vaccine Strain S2 in Mice and Guinea Pigs.

Authors:  Xiwen Wang; Zhiping Li; Bo Li; Hang Chi; Jiakuan Li; Hongchao Fan; Ruizhi Yao; Qianxue Li; Xiaolin Dong; Man Chen; Han Qu; Yuanyuan Wang; Weicun Gao; Yutian Wang; Yu Sun; Rui Sun; Jun Qian; Zhiping Xia
Journal:  Mol Imaging Biol       Date:  2016-08       Impact factor: 3.488

7.  Protection of mice against brucellosis by intranasal immunization with Brucella melitensis lipopolysaccharide as a noncovalent complex with Neisseria meningitidis group B outer membrane protein.

Authors:  Apurba K Bhattacharjee; Lillian Van de Verg; Mina J Izadjoo; Liang Yuan; Ted L Hadfield; Wendell D Zollinger; David L Hoover
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

Review 8.  What have we learned from brucellosis in the mouse model?

Authors:  María-Jesús Grilló; José María Blasco; Jean Pierre Gorvel; Ignacio Moriyón; Edgardo Moreno
Journal:  Vet Res       Date:  2012-04-13       Impact factor: 3.683

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.